For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms
The approval comes after a systematic review of published literature
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
Novavax’ clinical development program reported no severe allergic reactions
The NFI is published to promote the rational use of medicines in the country.
Subscribe To Our Newsletter & Stay Updated
